Orphan drugs – drugs used to treat rare diseases – affecting less than 200,000 people Manufacturers reluctant to develop – low potential for profitability – high cost to manufacture Orphan Drug Act enacted to facilitate the development of orphan drugs Tax breaks, subsidies, monopoly privileges